Gingival Treatment for Gum Recession in Diabetes

This trial examines the effectiveness of a specific gum treatment for individuals with and without diabetes. It seeks to determine if healing after treatment differs between these groups. The trial will also investigate factors such as oral bacteria and inflammation that might influence healing. Individuals with diabetes managed by medication or insulin who require treatment for receding gums may qualify. Participants will undergo a gum treatment procedure called Coronally Advance Flap with connective tissue graft (CAF+CTG) and attend several follow-up visits to provide samples and answer questions. As an unphased study, this trial offers a unique opportunity to enhance understanding of gum healing in diverse patient groups.

The trial requires that you do not take medications known to interfere with wound healing or that contraindicate the surgical procedure. If you are on such medications, you may need to stop them to participate.

Studies have shown that combining a coronally advanced flap with a connective tissue graft (CAF+CTG) is generally well-tolerated. Research indicates this method effectively covers exposed roots caused by gum recession. Many patients maintain stable results for up to 18 months post-procedure.

Researchers are excited about the Coronally Advance Flap associated with a connective tissue graft (CAF+CTG) for treating gum recession in people with diabetes because it offers a unique approach. Unlike standard treatments that might only involve scaling and root planing or medications to manage gum health, CAF+CTG physically restores gum tissue, possibly providing a more effective and lasting solution. This method combines a surgical technique that advances the gum tissue with a graft that encourages natural tissue regeneration, potentially leading to better coverage of exposed roots and improved gum stability. This could be particularly beneficial for diabetic patients, who often face challenges in wound healing.

Studies have shown that using a Coronally Advanced Flap with a connective tissue graft (CAF+CTG) effectively reduces gum recession. Patients treated with this method often experience significant improvement, as the treatment covers the exposed roots of their teeth. Research comparing CAF+CTG with other treatments indicates it achieves similarly good results in reducing gum recession. This trial will evaluate CAF+CTG in two groups: patients with diabetes and patients without diabetes. The method aims to cover exposed roots, which is crucial for individuals with gum recession. Overall, CAF+CTG has successfully managed gum recession, making it a promising option for patients with this condition.¹²³⁴⁶